These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15557618)

  • 21. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.
    Kennedy BJ; Novotny LA; Jurcisek JA; Lobet Y; Bakaletz LO
    Infect Immun; 2000 May; 68(5):2756-65. PubMed ID: 10768970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Protein E-PilA Fusion Protein Shows Vaccine Potential against Nontypeable Haemophilus influenzae in Mice and Chinchillas.
    Ysebaert C; Denoël P; Weynants V; Bakaletz LO; Novotny LA; Godfroid F; Hermand P
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.
    Bakaletz LO; Kennedy BJ; Novotny LA; Duquesne G; Cohen J; Lobet Y
    Infect Immun; 1999 Jun; 67(6):2746-62. PubMed ID: 10338477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas.
    Barenkamp SJ
    Infect Immun; 1996 Apr; 64(4):1246-51. PubMed ID: 8606086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression and Purification of C-terminal Fragment of the Passenger Domain of Hap Protein from Nontypeable Haemophilus influenzae in a Highly Optimized Escherichia coli Expression System.
    Tabatabaee A; Siadat SD; Moosavi SF; Aghasadeghi MR; Memarnejadian A; Pouriayevali MH; Yavari N
    Avicenna J Med Biotechnol; 2013 Jul; 5(3):176-85. PubMed ID: 23919121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
    Akkoyunlu M; Forsgren A
    APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization.
    Kodama S; Suenaga S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2000 Apr; 68(4):2294-300. PubMed ID: 10722632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Abe N; Suzuki M
    Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
    Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
    Noda K; Kodama S; Umemoto S; Abe N; Hirano T; Suzuki M
    Vaccine; 2010 Jul; 28(31):5068-74. PubMed ID: 20478344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontypeable Haemophilus influenzae as a pathogen in children.
    Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
    Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural determinants of the interaction between the Haemophilus influenzae Hap autotransporter and fibronectin.
    Spahich NA; Kenjale R; McCann J; Meng G; Ohashi T; Erickson HP; St Geme JW
    Microbiology (Reading); 2014 Jun; 160(Pt 6):1182-1190. PubMed ID: 24687948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A; Riesbeck K; Janson H
    Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae.
    Kyd JM; Taylor D; Cripps AW
    Infect Immun; 1994 Dec; 62(12):5652-8. PubMed ID: 7960148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
    Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
    Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human milk secretory IgA antibody to nontypeable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization.
    Harabuchi Y; Faden H; Yamanaka N; Duffy L; Wolf J; Krystofik D
    J Pediatr; 1994 Feb; 124(2):193-8. PubMed ID: 8301421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection].
    Augustynowicz E; Zawadka M; Wiatrzyk A; Rabczenko D; Lutyńska A
    Med Dosw Mikrobiol; 2013; 65(1):1-10. PubMed ID: 24180126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.